Treatment of hemophilia B in mice with nonautologous somatic gene therapeutics

Journal of Laboratory and Clinical Medicine

Volumn 139, Issue 1, 2002, Pages 35-42

  Van Raamsdonk, J M ^a,b,c   Ross, C J D ^a,b,c   Potter, M A ^a,b,c   Kurachi, S ^a,b,c   Kurachi, K ^a,b,c   Stafford, D W ^a,b,c   Chang, P L ^a,b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; CD4 ANTIGEN;

ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; GENE THERAPY; GENETICS; HEMOPHILIA B; HUMAN; IMMUNOLOGY; MALE; MOUSE; PHYSIOLOGY; PROTHROMBIN TIME; SECRETION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD4; FACTOR IX; GENE THERAPY; HEMOPHILIA B; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTHROMBIN TIME;

EID: 0036008995     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2002.120649     Document Type: Article

References (30)

1. Hemophilia: An updated review
2. Molecular cloning of a cDNA encoding canine factor IX
3. A factor IX-deficient mouse model for hemophilia B gene therapy
4. A coagulation factor IX-deficient mouse model for human hemophilia B
5. Targeted inactivation of the coagulation factor IX gene causes hemophilia B in mice
6. Long-term expression of human factor IX cDNA in rabbits
7. Ex vivo fibroblast transduction in rabbits results in long-term (>600 days) factor IX expression in a small percentage of animals
8. In vivo gene therapy of hemophilia B: Sustained partial correction in factor IX-deficient dogs
9. In vivo hepatic gene therapy: Complete albeit transient correction of factor IX deficiency in hemophilia B dogs
10. Gene therapy for hemophilia B: Host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression
11. Human factor IX corrects the bleeding diathesis of mice with hemophilia B
12. Persistent systemic production of human factor IX in mice by skeletal myoblast-mediated gene transfer: Feasibility of repeat application to obtain therapeutic levels
13. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system
14. Adenovirus-mediated transfer of human factor IX gene in immunodeficient and normal mice: Evidence for prolonged stability and activity of the transgene in liver
15. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus
16. Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia
17. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors
18. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors
19. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
20. Nonautologous somatic gene therapy
21. Delivery of human factor IX in mice by encapsulated recombinant myoblasts: A novel approach towards allogeneic gene therapy of hemophilia B
22. Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts - An alternate approach to somatic gene therapy
23. Somatic gene therapy of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cells
24. Somatic gene therapy of a neurodegenerative lysosomal storage disease using microencapsulated recombinant cells
25. Persistent delivery of factor IX in mice: Gene therapy for hemophilia using implantable microcapsules
26. Expression of human factor IX microencapsulated recombinant fibroblasts
27. The osmotic pressure test: A simple, quantitative method to assess the mechanical stability of alginate microcapsules
28. Suppression of immunological response against a transgene product delivered from microencapsulated cells
29. Partial correction of hemophilia A with neo-antigenic murine factor VIII in a murine model